Prof Jean Ferrières is an expert in Cardiology at Centre Hospitalier Universitaire de Toulouse (France). As of October 2026, ScienceLeadR ranks Jean Ferrières in the top 1% of experts worldwide for Dyslipidemias, Lipid Metabolism Disorders and Myocardial Ischemia. Jean Ferrières has authored 955 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 1 of them ongoing. SLR score: 2,717 (community average: 125). How the SLR is computed.

LeadR Profile

2 717 ScienceLeadR Reputation 2717
Network Map

Cardiology

Subspecialties: Public Health - Endocrinology - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Toulouse

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Unsupervised clustering identifies distinct phenotypes in acute myocardial infarction: insights from the FAST-MI 2015 registry.
PMID 42689178 — registries, mortality, myocardial infarction, phenotype, classification, acute coronary syndrome, cluster analysis, precision medicine, prognosis
Front Artif Intell20260
Sitosterolemia misdiagnosed as homozygous familial hypercholesterolemia: A diagnostic challenge.
PMID 42403461 — hyperlipoproteinemia type ii, ezetimibe, sterols, diagnosis, therapeutics, plasma, hypercholesterolemia, homozygous familial hypercholesterolemia
Am J Prev Cardiol20260
Low-density lipoprotein cholesterol management and goal attainment at 1 year in patients with diabetes, pre-diabetes and normoglycaemia: results from the European, prospective, observational SANTORINI study.
PMID 42373176 — diabetes mellitus, cholesterol, ldl, lipoproteins, cholesterol, therapeutics, lipoproteins, ldl
BMJ Open20260
Longitudinal changes in NT-proBNP after breast cancer radiotherapy: clinical determinants of its trajectory and association with cardiac dysfunction (BACCARAT study).
PMID 42290894 — radiotherapy, breast neoplasms, neoplasms, biomarkers, breast, therapeutics
Clin Transl Radiat Oncol20260
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI study.
PMID 42291044 — achievement, ezetimibe, cholesterol, ldl, cholesterol, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors
Am J Prev Cardiol20261

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1

By phase:

N/A 14

By status:

Completed 8
Recruiting 3
Active not recruiting 1
Unknown 1
Withdrawn 1

By type:

Observational 11
Interventional 3

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Identification of New Biomarkers for the Prediction of Cardiovascular Events
NCT04809506 — blood, cardiovascular diseases, biomarkers, polymorphism, genetic, atherosclerosis, thrombosis
N/ARecruiting2021

LeadR Networks

Main global connection map